
Jean-Pierre Bizzari is Chairman of the Board of NETRIS Pharma. He is also a Board member of Oxford BioTherapeutics, Aprea Therapeutics and ADC Therapeutics, a member of the Scientific Advisory Board of the National Cancer Institute in France, and Chairman of the EORTC New Drug Advisory Committee in Belgium.
With a strong track record in oncology clinical development, Jean-Pierre previously served as Vice President, Head of Oncology Clinical Development at Celgene and Sanofi-Aventis.
He holds a medical degree from the University of Nice and is a trained oncologist at Pitié-Salpêtrière Hospital in Paris.